(A) B-CLL cells from patients with unmutated IGHV had greater induced signaling. Dashed line represents unmodulated signal. (B) Prior to unblinding clinical data, it was pre-specified that samples having reduced bendamustine-induced p21 expression levels would carry p53 mutations.